News

Add Dabur India Ltd For Target Rs.s 160 - Yes Securities Ltd Result Synopsis Orient Cement's (ORCMNT) result was below expectation on all fronts, volume missed by 8% (+16% y/y) due to Chittapur plant maintenance shutdown, causing revenue 5% below YSECe (+16% y/y). Additionally, +10% higher total cost/te than est. resulted in EBITDA/PAT miss of 33/46% in Q1FY24. The inter-clinker movement & other cost surged due to the maintenance shutdown at Chittapur unit kept total cost elevated thereby dented EBITDA/te to Rs624, declined by 16% y/y (v/s R...
Add Dabur India Ltd For Target Rs.s 160 - Yes Securities Ltd
Add Dabur India Ltd For Target Rs.s 160 - Yes Securities Ltd
Source: Yes Securities Ltd
4/08/2023 12:05:17 PM
Add Dabur India Ltd For Target Rs.660 - Yes Securities Ltd * DABUR’s 1QFY24 result was broadly in line with our estimates in all aspects. It reported volume growth in both rural and urban markets, with an increase in distribution reach and market share. * HPC and HC showed moderation in RM inflation, while the food inflation remained high. It led GP margin expansion of 70bp YoY. With increase in media spending, EBITDA margin remains flat at 19.3%. * Allied with synergies in the healthcare portfolio, it expects to achieve double-digit cons...
Add Dabur India Ltd For Target Rs.660 - Yes Securities Ltd
Add Dabur India Ltd For Target Rs.660 - Yes Securities Ltd
Source: Motilal Oswal Financial Services Ltd
4/08/2023 11:28:31 AM
Dabur India reports 5.4% rise in Q1 profit Consumer goods-maker Dabur India reported a rise in first-quarter profit on Thursday as demand rose on easing inflation. The company's consolidated net profit rose 5.4% year-on-year to 4.64 billion rupees ($56.1 million) in the quarter ended June 30. ($1 = 82.7900 Indian rupees)
Dabur India reports 5.4% rise in Q1 profit
Dabur India reports 5.4% rise in Q1 profit
Source: Reuters
3/08/2023 2:47:41 PM
Colgate-Palmolive's Indian unit reports Q1 profit rise on demand recovery Toothpaste maker Colgate-Palmolive (India)'s quarterly profit rose 30.5% on Wednesday, aided by improved domestic demand. Net profit rose to 2.74 billion rupees ($33.40 million) for the quarter ended June 30 compared to 2.10 billion rupees a year earlier. Steady rural demand pick-up and some ease in domestic retail inflation helped Indian consumer goods companies log gains during the quarter. Sales rose nearly 10.8% to 13.15 billion rupees, boosted by the company's mainstay o...
Colgate-Palmolive's Indian unit reports Q1 profit rise on demand recovery
Colgate-Palmolive's Indian unit reports Q1 profit rise on demand recovery
Source: Reuters
26/07/2023 8:10:18 PM
Stock of the day: Buy Dabur Ltd For Target Rs. 590 - Religare Broking DABUR LTD * We are seeing consistent buying in the FMCG space and Dabur is trading in sync with the trend. * After the marginal dip to the short term moving average, it looks set for a rebound again. * The chart pattern indicates gradual recovery towards the previous swing high. * We thus recommend creating fresh longs in the mentioned range. Buy Dabur Ltd CMP 563.35; Range 562-564; SL 548; Target 590   To Read Complete Report & Disclaimer ...
Stock of the day: Buy Dabur Ltd For Target Rs. 590 - Religare Broking
Stock of the day: Buy Dabur Ltd For Target Rs. 590 - Religare Broking
Source: Religare Broking Ltd
26/06/2023 11:51:05 AM
Stock of the day: Buy Dabur India Ltd For Target Rs.584 - Religare Broking Dabur India Ltd  * FMCG is among the top performing sector. Dabur is catching up with the move. * After the consolidation breakout, formed a fresh buying pivot while holding above the moving averages ribbon. * The chart pattern and confirmation indicators are in sync for steady up move. * We thus recommend creating fresh longs in the mentioned range   Buy Dabur India Ltd  CMP 562.35; Range 562-564; SL 552; Target 584     To Rea...
Stock of the day: Buy Dabur India Ltd For Target Rs.584 - Religare Broking
Stock of the day: Buy Dabur India Ltd For Target Rs.584 - Religare Broking
Source: Religare Broking Ltd
15/06/2023 11:35:24 AM
Colgate-Palmolive's India unit beats Q4 profit view on price hikes Colgate-Palmolive (India) Ltd's fourth-quarter profit fell less than expected, helped by price hikes implemented to combat surging costs. The Indian arm of the U.S. consumer goods major reported a 2.3% fall in net profit to 3.16 billion rupees ($38.64 million) for the quarter ended March 31. Analysts, on average, had expected a profit of 2.71 billion rupees, according to Refinitiv IBES. The net profit includes a one-time tax reversal, barring which it had risen nearly 9%. The ...
Colgate-Palmolive's India unit beats Q4 profit view on price hikes
Colgate-Palmolive's India unit beats Q4 profit view on price hikes
Source: Reuters
12/05/2023 5:46:29 PM
India's P&G Hygiene and Health Care posts drop in Q3 sales on muted demand India's Procter & Gamble Hygiene and Health Care Ltd reported a dip in quarterly sales on Wednesday, as a pandemic-driven demand for healthcare products waned with new COVID cases dropping across the country. The company said sale of its products, ranging from Vicks inhaler to Whisper sanitary napkin, fell about 1% to 8.81 billion rupees ($107.73 million) in the January-March quarter. Sales surge in the comparable quarter a year earlier was Omicron-driven, the company said in an...
India's P&G Hygiene and Health Care posts drop in Q3 sales on muted demand
India's P&G Hygiene and Health Care posts drop in Q3 sales on muted demand
Source: Reuters
11/05/2023 9:14:33 AM
Add Dabur India Ltd For Target Rs.590 - Yes Securities Ltd Dabur India Ltd. (DABUR) 4QFY23 operating performance was significantly lower than our estimate as indicated by the company in their pre-quarterly update. The miss was largely on account of increased A&P spends & unfavorable mix in domestic business, along with currency headwinds in International Business. Going ahead, Dabur is seeing some revival in rural demand. Inflation is also moderating, which means gross margin profile will keep on improving but company will prioritize normaliz...
Add Dabur India Ltd For Target Rs.590 - Yes Securities Ltd
Add Dabur India Ltd For Target Rs.590 - Yes Securities Ltd
Source: Yes Securities Ltd
6/05/2023 3:31:51 PM
Buy Dabur India Ltd For Target Rs.595 - Motilal Oswal Financial Services Ltd * Revenue was in line with our estimates in 4QFY23. Volumes grew ~1% v/s our expectation of 5%. Rural markets remained lackluster; however, the management witnessed some green shoots at the end of the quarter. * EBITDA margin contracted 270bp YoY to 15.3%, the lowest in the last 35 quarters. It was affected by an adverse product mix, a step-up in media spends and one-off expenses to the tune of INR250-300m. It seems margin has hit the trough; however, a recovery to 20% EBITDA margin would ...
Buy Dabur India Ltd For Target Rs.595 - Motilal Oswal Financial Services Ltd
Buy Dabur India Ltd For Target Rs.595 - Motilal Oswal Financial Services Ltd
Source: Motilal Oswal Financial Services Ltd
5/05/2023 11:40:27 AM
Dabur to make additional investment of Rs 9.68 bn in Nepal Indian fast-moving consumer goods company Dabur has decided to make an additional investment of Rs 9.68 billion in Nepal. The Investment Board Nepal and Dabur Nepal Pvt. Ltd. signed a memorandum of understanding on Thursday for the construction, operation, and management of capacity building and product diversification projects under the private investment concept. Though the Investment Board Nepal had approved the additional investment by Dabur in February last year, the MoU was signed...
Dabur to make additional investment of Rs 9.68 bn in Nepal
Dabur to make additional investment of Rs 9.68 bn in Nepal
Source: IANS
28/04/2023 9:19:20 AM
Stock Picks : Dabur India and Chambal Fertilizers By ICICI Direct Dabur India (DABIND) Dabur India (DABIND) CMP 541.45 Stop Loss 536.30 Target 547.80   Chambal Fertilizers Chambal Fertilizers CMP 254.95 Stop Loss 258.60 Target 252.70   To Read Complete Report & Disclaimer Click Here   Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631   Above views are of the aut...
Stock Picks : Dabur India and Chambal Fertilizers By ICICI Direct
Stock Picks : Dabur India and Chambal Fertilizers By ICICI Direct
Source: ICICI Direct
28/03/2023 12:00:10 PM
Stock Picks : Grasim Ltd and Indian Dabur India Ltd By ICICI Direct Grasim Ltd Buy Grasim Ltd @ 1584-1587 CMP 1592.00 Stop Loss 1573.70 Target 1604.00   Dabur India Ltd  Buy Dabur India Ltd @ 536-537 CMP  537.10 Stop Loss 532.80 Target 543.40     To Read Complete Report & Disclaimer Click Here   Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ0001836...
Stock Picks : Grasim Ltd and Indian Dabur India Ltd By ICICI Direct
Stock Picks : Grasim Ltd and Indian Dabur India Ltd By ICICI Direct
Source: ICICI Direct Ltd
21/03/2023 10:12:19 AM
Dabur India`s sales growth hits 10-quarter low on dull rural demand Dabur India Ltd reported a 5% drop in third-quarter profit on Thursday, with its revenue growth slumping to a ten-quarter low as customers in rural areas, reeling from the impact of high living costs, tightened spending. The company, which makes products including shampoos and hair oil, said net income fell to 4.76 billion rupees (about $58 million) in the quarter ended Dec. 31, from 5.03 billion rupees a year earlier. Its revenue from operations rose 3% to 30.43 billion rupees - markin...
Dabur India`s sales growth hits 10-quarter low on dull rural demand
Dabur India`s sales growth hits 10-quarter low on dull rural demand
Source: Reuters
2/02/2023 3:28:20 PM
Dabur India expects Q3 revenue to rise on late demand pickup CHENNAI- Consumer goods maker Dabur India Ltd said on Friday its consolidated quarterly revenue would likely increase in the low-tomid-single digit percentage range, benefiting from a pickup in demand late in the third quarter.  
Dabur India expects Q3 revenue to rise on late demand pickup
Dabur India expects Q3 revenue to rise on late demand pickup
Source: Reuters
6/01/2023 1:36:19 PM
Dabur India gains on acquiring 51% stake in Badshah Masala Dabur India is currently trading at Rs. 562.90, up by 1.15 points or 0.20% from its previous closing of Rs. 561.75 on the BSE. The scrip opened at Rs. 563.60 and has touched a high and low of Rs. 568.35 and Rs. 562.30 respectively. So far 14787 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 610.40 on 07-Dec-2022 and a 52 week low of Rs. 482.20 on 17-Jun-2022. Last one week high and low of the scrip stood at Rs....
Dabur India gains on acquiring 51% stake in Badshah Masala
Dabur India gains on acquiring 51% stake in Badshah Masala
Source: Accord Fintech
3/01/2023 10:30:56 AM
Stock of the day: Buy Dabur India Ltd For Target Rs.582 By Religare Broking * Dabur has retraced considerably from its top and tested the support around its medium-term moving average i.e. (100 EMA )on the daily chart. * Indications are in the favor of marginal consolidation around the current levels, followed by a rebound. * We thus recommend accumulating in the given range. BUY Dabur India Ltd CMP (Rs):565.50  Range:560-563  SL:552  Target:582 Technical Chart :     To Read Complete Report & Discla...
Stock of the day: Buy Dabur India Ltd For Target Rs.582 By Religare Broking
Stock of the day: Buy Dabur India Ltd For Target Rs.582 By Religare Broking
Source: Religare Broking Ltd
27/12/2022 9:44:30 AM
Key Stock News: IIFL fintech , M3M India, Vedanta, Byju's, Glenmark Pharma, Dabur - ARETE Securities IIFL fintech fund picks up 16% in Insurance Samadhan for $2 million The IIFL Group's early-stage investment vehicle, IIFL Fintech Fund, has invested USD 2 million (around Rs 16.5 crore) in insurance technology startup Insurance Samadhan for a 16 per cent stake, valuing the platform at around USD 13 million (around Rs 107 crore). The startup also received another USD 1 million from other investors in the series-A round. This is IIFL fintech fund's 10th investment and first in the...
Key Stock News: IIFL fintech , M3M India, Vedanta, Byju's, Glenmark Pharma, Dabur - ARETE Securities
Key Stock News: IIFL fintech , M3M India, Vedanta, Byju's, Glenmark Pharma, Dabur - ARETE Securities
Source: ARETE Securities Ltd
22/12/2022 9:59:11 AM
Dabur falls after entities of Burman family sell 1% stake in the company Dabur India is currently trading at Rs. 576.90, down by 2.95 points or 0.51% from its previous closing of Rs. 579.85 on the BSE. The scrip opened at Rs. 582.00 and has touched a high and low of Rs. 586.55 and Rs. 574.55 respectively. So far 43768 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 610.40 on 07-Dec-2022 and a 52 week low of Rs. 482.20 on 17-Jun-2022. Last one week high and low of the scrip stood at R...
Dabur falls after entities of Burman family sell 1% stake in the company
Dabur falls after entities of Burman family sell 1% stake in the company
Source: Accord Fintech
21/12/2022 3:21:33 PM
Buy Dabur India Ltd For Target Rs.700 - ICICI Direct Leveraging brand, reach to grow in new categories About the stock: Dabur India (DIL) is one of the biggest FMCG companies with a presence in Ayurveda based products across categories. The company has a substantial market share in health supplement, OTC & Ethical products, oral care, hair care, home care & juices. * The company has a total distribution reach of 6.9 million retail outlets with direct reach of 1.3 million outlets. It plans to increase direct distribution to 1.5 mil...
Buy Dabur India Ltd For Target Rs.700 - ICICI Direct
Buy Dabur India Ltd For Target Rs.700 - ICICI Direct
Source: ICICI Direct Ltd
31/10/2022 12:01:44 PM
Dabur India zooms on getting nod to invest Rs 325.87 crore in Indore plant Dabur India is currently trading at Rs. 547.20, up by 15.10 points or 2.84% from its previous closing of Rs. 532.10 on the BSE. The scrip opened at Rs. 548.10 and has touched a high and low of Rs. 548.75 and Rs. 536.50 respectively. So far 69946 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 620.00 on 08-Nov-2021 and a 52 week low of Rs. 482.20 on 17-Jun-2022. Last one week high and low of the scrip stood at Rs...
Dabur India zooms on getting nod to invest Rs 325.87 crore in Indore plant
Dabur India zooms on getting nod to invest Rs 325.87 crore in Indore plant
Source: Accord Fintech
27/10/2022 3:10:45 PM
India`s Dabur reports drop in profit on higher costs, demand weakness  Consumer goods major Dabur India reported a 2.8% fall in second-quarter profit on Wednesday, as sales moderated and higher commodity prices weighed on margins. The impact of inflationary pressures was more pronounced in the rural markets where demand growth was slower compared to urban areas for the first time in five quarters. The company expects a recovery in rural demand in the coming quarters. "While the challenging economic environment continued to be a concern...
India`s Dabur reports drop in profit on higher costs, demand weakness
India`s Dabur reports drop in profit on higher costs, demand weakness
Source: Reuters
26/10/2022 4:12:04 PM
Buy Dabur India Ltd For Target Rs.670 - ICICI Securities Dabur reported a decent print (+10% YoY India revenue, +5% YoY volume growth) with Foods and Beverages managing the show well. While Healthcare performance appears unexciting (lapping a high base), the HPC category did reasonably well. That said, the performance was decent on an overall basis. Dabur is pursuing growth in (1) Foods and Beverages portfolio with continued portfolio expansion and (2) aggressive plans in HPC portfolio (requires some improvement in market scenario). We note that...
Buy Dabur India Ltd For Target Rs.670 - ICICI Securities
Buy Dabur India Ltd For Target Rs.670 - ICICI Securities
Source: ICICI Securities Ltd
14/10/2022 5:54:00 PM
Key Stock News: HCLTech, HUL, Morgan Stanley, Ambuja Cements, Dabur, Suzlon Energy - ARETE Securities Key News HCLTech to boost presence in Mexico; to hire 1300 employees over next 2 yrs HCLTech on Saturday announced plans to scale up its operations in Mexico by opening a new technology centre in Guadalajara city and hiring 1300 employees over the next two years amid concerns over high attrition levels. The new centre in Guadalaraja will enable the company to serve its local and international client base across industries. It will be the sixth technology centre in Mexico and will focus ...
Key Stock News: HCLTech, HUL, Morgan Stanley, Ambuja Cements, Dabur, Suzlon Energy - ARETE Securities
Key Stock News: HCLTech, HUL, Morgan Stanley, Ambuja Cements, Dabur, Suzlon Energy - ARETE Securities
Source: ARETE Securities Ltd
10/10/2022 9:34:17 AM
Update On: Dabur India Ltd By Motilal Oswal Financial Services Clocks mid-single digit growth in 2QFY23; gains market share across its portfolio DABUR released its pre-quarterly update for 2QFY23. Here are the key highlights: Consumption * Demand was weak across categories due to unprecedented inflation in 2QFY23. * Consumption in urban India was driven by modern trade and e-commerce, which saw double-digit growth. * Rural markets witnessed liquidity pressures. * The management expects consumption to grow in 2HFY23 on the back of modera...
Update On: Dabur India Ltd By Motilal Oswal Financial Services
Update On: Dabur India Ltd By Motilal Oswal Financial Services
Source: Motilal Oswal Financial Services Ltd
7/10/2022 2:52:41 PM
Dabur India flags up to 200 bps margin hit in Q2 as inflation bites Consumer goods major Dabur India on Thursday warned that soaring inflation during the second quarter could lower its operating margin by around 150-200 basis points year-on-year, while revenue likely grew in mid-single digits. "During the quarter, inflation was at peak levels which impacted gross margins," Dabur said in a regulatory filing. However, the maker of toothpaste and packaged juices expects easing commodity prices to help improve margins in the second half of the year. ...
Dabur India flags up to 200 bps margin hit in Q2 as inflation bites
Dabur India flags up to 200 bps margin hit in Q2 as inflation bites
Source: Reuters
6/10/2022 5:21:20 PM
Stock Picks - Sun Pharma Ltd and Dabur India Ltd By ICICI Direct Sun Pharma Ltd Buy Sun Pharma Ltd @ 901.00-904.00 CMP 908.00 Stop Loss 893 Target 910.80/919.80   Dabur India Ltd Buy Dabur India Ltd @ 901.00-904.00 CMP 908.00 Stop Loss 893 Target 910.80/919.80   To Read Complete Report & Disclaimer Click Here   Please refer disclaimer at https://secure.icicidirect.com/Content/StaticData/Disclaimer.html SEBI Registration number INZ000183631   Above views are of the author and not ...
Stock Picks - Sun Pharma Ltd and Dabur India Ltd By ICICI Direct
Stock Picks - Sun Pharma Ltd and Dabur India Ltd By ICICI Direct
Source: ICICI Direct
23/09/2022 10:43:05 AM
Buy Dabur India Ltd For Target Rs.660 - Motilal Oswal Financial Services In line, margin to improve with a lag ? DABUR reported an in line 1QFY23 earnings. Despite indicating continued margin pressures in 2Q, the management aims to maintain FY23 margin at FY22 levels. ? Despite rural contributing half of its domestic sales, DABUR reported near identical growth in both rural and urban as a result of its efforts to boost rural distribution. This is unlike the broader Consumer category, where rural demand remains tepid. The company can benefit from the tailwind...
Buy Dabur India Ltd For Target Rs.660 - Motilal Oswal Financial Services
Buy Dabur India Ltd For Target Rs.660 - Motilal Oswal Financial Services
Source: Motilal Oswal Financial Services Ltd
14/09/2022 3:35:04 PM
Buy Dabur India Ltd For Target Rs. 650 - Centrum Broking Ltd In-line performance, though rural faring well Dabur’s Q1FY23 print was in-line with our estimates. Despite high base, consolidated revenue/APAT grew 8.1%/1.1%, while 2-year CAGR was 19.4%/13.7%. India FMCG business surged 10%, led by 5% volume growth. International business (23.5% of sales) grew 8.8% (CC). Bearing in mind high base (+35.4%), unsettled execution coupled with efforts on NPD, led Dabur to continue deliver reasonable performance. driven by rural distribution efforts and ...
Buy Dabur India Ltd For Target Rs. 650 - Centrum Broking Ltd
Buy Dabur India Ltd For Target Rs. 650 - Centrum Broking Ltd
Source: Centrum Broking Ltd
6/08/2022 12:37:12 PM
Dabur India gains on reporting marginal rise in Q1 consolidated net profit Dabur India is currently trading at Rs. 573.40, up by 3.90 points or 0.68% from its previous closing of Rs. 569.50 on the BSE. The scrip opened at Rs. 570.00 and has touched a high and low of Rs. 575.60 and Rs. 564.05 respectively. So far 81224 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 658.75 on 24-Sep-2021 and a 52 week low of Rs. 482.20 on 17-Jun-2022. Last one week high and low of the scrip stood at Rs....
Dabur India gains on reporting marginal rise in Q1 consolidated net profit
Dabur India gains on reporting marginal rise in Q1 consolidated net profit
Source: Accord Fintech
4/08/2022 4:02:35 PM
Dabur India trades in green on the BSE Dabur India is currently trading at Rs. 546.70, up by 1.55 points or 0.28% from its previous closing of Rs. 545.15 on the BSE. The scrip opened at Rs. 547.70 and has touched a high and low of Rs. 552.00 and Rs. 545.10 respectively. So far 17646 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 658.75 on 24-Sep-2021 and a 52 week low of Rs. 482.20 on 17-Jun-2022. Last one week high and low of the scrip stood at Rs....
Dabur India trades in green on the BSE
Dabur India trades in green on the BSE
Source: Accord Fintech
14/07/2022 12:55:49 PM
Buy Dabur India Ltd For Target Rs.650 - Centrum Broking Off high base expect 9.2% revenue growth in Q1 Dabur India Ltd. in its exchange filing today said that it witnessed pressure on consumption across categories led by a lower share of income available for spending on consumer staples. We note, in Q1FY22 Dabur reported revenue growth of 35.4% supported by 34% growth in volume. That said considering the impact in urban as well as rural markets we estimate 9.2% revenue growth in Q1FY23e. Segmental performance: Foods strong double digit growth; ...
Buy Dabur India Ltd For Target Rs.650 - Centrum Broking
Buy Dabur India Ltd For Target Rs.650 - Centrum Broking
Source: Centrum Broking Ltd
8/07/2022 12:50:49 PM
Large Cap: Buy Dabur India Ltd For Target Rs.560 - Geojit Financial Services Decent performance despite inflationary pressure Dabur India Ltd (Dabur), a leading Indian FMCG company, is a world leader in Ayurveda with a portfolio of over 250 Herbal/Ayurvedic products. The company operates through Health Supplements, Digestives, Shampoos, Hair Oils, Skin Care, Oral Care, Foods, and Other OTC & Ethical products * Q4FY22 revenue went up 7.7% YoY to Rs 2,518cr and 13.9% YoY for FY22 to Rs 10,889cr, largely led by increase in Food and Beverages revenues (+33.5%). ...
Large Cap: Buy Dabur India Ltd For Target Rs.560 - Geojit Financial Services
Large Cap: Buy Dabur India Ltd For Target Rs.560 - Geojit Financial Services
Source: Geojit Financial Services Ltd
12/05/2022 12:08:27 PM
Buy Dabur India Ltd @ 500-504, SLOSS AT 489, TRGT 525. - Religare Broking Derivative Ideas DABUR gained 0.91% and closed at 507.1 on 11th May. The FMCG sector has been seeing some correction and DABUR is no different. Now the stock found support at its important zone of 490-495 and saw a good intraday up move after that. The demand came with incremental volumes and Fresh Longs being added in its FUTS. We thus suggest initiating Longs as per the given levels Strategy:- BUY DABUR @ 500-504, SLOSS AT 489, TRGT 525.   To Read Complete Report &...
Buy Dabur India Ltd @ 500-504, SLOSS AT 489, TRGT 525. - Religare Broking
Buy Dabur India Ltd @ 500-504, SLOSS AT 489, TRGT 525. - Religare Broking
Source: Religare Broking Ltd
12/05/2022 12:05:39 PM
Buy Dabur India Ltd For Target Rs.609 - Yes Securities Inflation‐led demand slowdown impacts growth momentum; maintain BUY on reasonable valuations and decent growth outlook Our view While volume growth has normalized in last two quarters with 2% each given a high base, 2‐ yr revenue CAGR of 16%/12% in Q4FY22/FY22 indicates Dabur’s portfolio strength and share gains. Resilient growth of 7% in healthcare and strong performance from Foods business on a high base were key positives. Its International business continues to grow in double‐...
Buy Dabur India Ltd For Target Rs.609 - Yes Securities
Buy Dabur India Ltd For Target Rs.609 - Yes Securities
Source: Yes Securities Ltd
7/05/2022 11:01:05 AM
Buy Dabur India Ltd For Target Rs.630 - Motilal Oswal Sales visibility and pricing power augur well DABUR’s 4QFY22 result was broadly in line with our volume, sales, and gross profit estimates, but higher other expenses led to a miss on EBITDA. The outlook for Juices is positive, given the robust summer demand. The demand and margin outlook for the international business is strong in FY23. Allied with higher pricing power in the Healthcare business, we remain positive on double-digit consolidated sales growth in FY23. Higher prici...
Buy Dabur India Ltd For Target Rs.630 - Motilal Oswal
Buy Dabur India Ltd For Target Rs.630 - Motilal Oswal
Source: Motilal Oswal Financial Services Ltd
6/05/2022 12:03:57 PM
Key News - Adani Power, Paytm, Morepen Laboratories Ltd, ABB India, Ltd, Dabur By ARETE Securities Key News Adani Power Q4: Net profit surges to Rs 4,645 cr due to higher revenues Adani Power's consolidated net profit jumped to Rs 4,645.47 crore in the March quarter from Rs 13.13 crore in the year-ago period, mainly on the back of higher revenues. Total income of the company rose to Rs 13,307.92 crore in the quarter ended on March 31, 2022 from Rs 6,902.01 crore in the same period a year ago, it said in a statement on Thursday. The consolidated net profit fo   JPIN ...
Key News - Adani Power, Paytm, Morepen Laboratories Ltd, ABB India, Ltd, Dabur By ARETE Securities
Key News - Adani Power, Paytm, Morepen Laboratories Ltd, ABB India, Ltd, Dabur By ARETE Securities
Source: ARETE Securities Ltd
6/05/2022 9:38:40 AM
Key News - Myntra ,Flipkart, Qatar Airways , Dabur, By ARETE Securities Procter & Gamble names L V Vaidyanathan as CEO for India operations Global FMCG firm Procter & Gamble on Tuesday announced the appointment of L V Vaidyanathan as the Chief Executive Officer for its operations in India from July 1, 2022. Vaidyanathan will take over from Madhusudan Gopalan, who will be taking up a leadership role within P&G as Senior Vice President Grooming & Oral Care, P&G Japan and Korea, the company said in a statement. Currently he is leading P&...
Key News - Myntra ,Flipkart, Qatar Airways , Dabur, By ARETE Securities
Key News - Myntra ,Flipkart, Qatar Airways , Dabur, By ARETE Securities
Source: ARETE Securities Ltd
20/04/2022 9:52:36 AM
Buy Dabur India Ltd For Target Rs.600 - Emkay Global Steady performance; healthcare Dabur reported in-line performance in Q3, with sales growing 8% to Rs29.4bn and PAT growing 2% (lower due to high ETR). The domestic business grew 7%, with volume growth slowing to 2%, largely due to a decline in health supplements on a high base. Management expects industry-beating growth in rural, aided by distribution expansion. The pace of new launches remains aggressive, contributing 3.6%. It expects strong traction in foods, led by share gains in jui...
Buy Dabur India Ltd For Target Rs.600 - Emkay Global
Buy Dabur India Ltd For Target Rs.600 - Emkay Global
Source: Emkay Global Financial Services Ltd
7/04/2022 3:03:58 PM
Buy Dabur India Ltd For Target Rs.745 - ICICI Direct Expanding addressable market… About the stock: Dabur India (DIL) is one of the biggest FMCG companies with a presence in Ayurveda based products across categories. The company has a dominant market share in health supplement, OTC & ethical products, hair oils & Juices. Moreover, it is continuously gaining market share in oral care category. The company has a total distribution reach of 6.9 million retail outlets with direct reach of 1.3 million outlets. It would increase ...
Buy Dabur India Ltd For Target Rs.745 - ICICI Direct
Buy Dabur India Ltd For Target Rs.745 - ICICI Direct
Source: ICICI Direct
14/03/2022 11:40:53 AM
Buy Dabur India Ltd For Target Rs.705 - Motilal Oswal Resilient results given high rural dependence DABUR’s 3QFY22 results were in line with our estimates. The double-digit two-year CAGR on volumes, sales, EBITDA, and PAT is particularly creditable given its a) higher rural exposure v/s peers and b) some ongoing moderation from the extremely high sales levels in Healthcare as the intensity of the pandemic abates. Market share gains across the portfolio are heartening, as is the progress in e-commerce sales and modern trade (MT), area...
Buy Dabur India Ltd For Target Rs.705 - Motilal Oswal
Buy Dabur India Ltd For Target Rs.705 - Motilal Oswal
Source: Motilal Oswal Financial Services Ltd
3/03/2022 12:55:21 PM
Buy Dabur India Ltd For Target Rs.680 - ICICI Securities Headline may not please consensus; however, strong underlying trends We stay longstanding believers in Mohit Malhotra-led reimagining of Dabur. 3Q performance was in line with our estimates – 2-year revenue CAGR print of ~12% and domestic volume growth of ~10% (again 2-year CAGR). Dabur continued to highlight outperformance across the portfolio with company gaining share in most of them. The performance was broad-based with Foods (including Beverages) continuing to perform well. Inno...
Buy Dabur India Ltd For Target Rs.680 - ICICI Securities
Buy Dabur India Ltd For Target Rs.680 - ICICI Securities
Source: ICICI Securities Ltd
23/02/2022 2:15:54 PM
Buy Dabur India Ltd For Target Rs.548 - Motilal Oswal POWERing ahead by leveraging its core strengths Potential for sustained double-digit topline growth; attractive at current levels We reiterate our BUY rating on DABUR with a TP of INR705, implying 29% potential upside. Our investment thesis on DABUR is premised on the following key attributes: a) highest topline growth visibility among peers, b) consistent market share gains across categories, and c) potential to record even faster earnings growth post-completion of its ongoing investme...
Buy Dabur India Ltd For Target Rs.548 - Motilal Oswal
Buy Dabur India Ltd For Target Rs.548 - Motilal Oswal
Source: Motilal Oswal Financial Services Ltd
21/02/2022 1:10:43 PM
Buy Dabur India Ltd For Target Rs.650 - Yes Securities Strong volume traction with share gains across segments; stable outlook on growth and margins; upgrade to BUY Our view Dabur continues to deliver one of the best underlying growth performance in the staples space with a 12% 2-yr revenue CAGR with market share gains in each segment. The company also continues to grow much faster in rural markets than urban markets, again in stark contrast to peers and the industry given its rural distribution initiatives. Its brands in healthcare, oral c...
Buy Dabur India Ltd For Target Rs.650 - Yes Securities
Buy Dabur India Ltd For Target Rs.650 - Yes Securities
Source: Yes Securities Ltd
11/02/2022 9:58:41 AM
Buy Dabur India Ltd For Target Rs.720 - Edelweiss Financial Services Long term intact in spite of a soft Q3 Dabur has corrected roughly 12% from peak due to concerns on rural slowdown, late winter and the recent upheaval in Turkish lira. While Q3FY22 will be impacted due to these factors, especially given a very high base of 18% volume growth, we expect Q4FY22 to benefit from: i) immunity products to see a spike due to rising Covid wave 3; ii) harsh winter has finally set in spurring sales of winter products. Maintain ‘BUY’ with a TP of INR72...
Buy Dabur India Ltd For Target Rs.720 - Edelweiss Financial Services
Buy Dabur India Ltd For Target Rs.720 - Edelweiss Financial Services
Source: Edelweiss Financial Services Ltd
15/01/2022 12:30:00 PM
Buy Dabur India Ltd For Target Rs.700 - ICICI Securities Aggression at its best – gaining shares in an expanded opportunity We are longstanding believers in Mohit Malhotra-led reimagining of Dabur. 2Q performance has surprised positively with 2-year revenue CAGR print of 12.9% (highest in 7+ years) and domestic volume growth of 10%. Importantly, it achieved outperformance across the portfolio. It does not matter whether Dabur is a leader or a challenger in a category, its gaining share in most of them. Furthermore, the focus seems back on ...
Buy Dabur India Ltd For Target Rs.700 - ICICI Securities
Buy Dabur India Ltd For Target Rs.700 - ICICI Securities
Source: ICICI Securities Ltd
14/12/2021 9:41:18 AM
Buy Dabur India Ltd For Target Rs.745 - ICICI Direct On a roll… About the stock: Dabur India (DIL) is one of the biggest FMCG companies with a presence in Ayurveda based products across categories. The company has a dominant market share in health supplement, OTC & ethical products, hair oils & juices. Moreover, it is continuously gaining market share in the oral care category. * The company has total distribution reach of 6.9 million retail out with direct reach of 1.3 million outlets. It would increase direct distribution...
Buy Dabur India Ltd For Target Rs.745 - ICICI Direct
Buy Dabur India Ltd For Target Rs.745 - ICICI Direct
Source: ICICI Direct
7/12/2021 8:57:06 AM
Buy Dabur Ltd For Target Rs.705 - Motilal Oswal Result better than expected; margin headwinds lesser than peers * Driven by very strong growth in HPC and more so in F&B, DABUR’s 2QFY22 result comfortably beat our sales growth forecasts, even as Healthcare sales, as expected, slowed down on the back of a high base. * Healthcare sales posted a 19% CAGR over a two-year period, and its medium-term prospects are attractive. * Consolidated sales/volume growth of 12%/10% YoY in 2QFY22 on a growth of 14%/17% in the base quarter ...
Buy Dabur Ltd For Target Rs.705 - Motilal Oswal
Buy Dabur Ltd For Target Rs.705 - Motilal Oswal
Source: Motilal Oswal Financial Services Ltd
30/11/2021 10:10:17 AM